Archive for December, 2015

CNTR Advocacy Results in $10 Million for Trauma Clinical Research Program

Tuesday, December 22nd, 2015

On Friday, December 18th, the U.S. Congress passed a $1.1 trillion omnibus spending bill for 2016 and sent it to President Obama, who signed the bill into law that afternoon. The measure includes $10 million in the 2016 Department of Defense (DoD) Health Program account for a national Trauma Clinical Research Program.

Advocates from the Coalition for National Trauma Research (CNTR) had requested funding for the program, which will create a coordinated, multi-institution, clinical research network to advance experience with and study of military-relevant topics in trauma care and trauma systems. The network of research centers sought by the Department of Defense will investigate improved treatments for traumatic injuries suffered by our soldiers, many of which are similar to the injuries suffered by civilians on a massive scale, including those injuries related to vehicle collisions and violence.

“Trauma has become one of the gravest and most costly health problems in America,” said William Cioffi, MD, a professor and Chair of Surgery at the Alpert Medical School of Brown University, and past president of the American Association for the Surgery of Trauma (AAST), a CNTR member. “The national Trauma Clinical Research Program will, for the first time, coalesce resources and focus on a national agenda so that research centers can collectively arrive at solutions to the biggest challenges.”

“Collaborative efforts between military and civilian trauma practitioners have the ability to rapidly advance our understanding of injury care,” added Thomas Scalea, MD, immediate past president of AAST, professor of Surgery at the University of Maryland School of Medicine and Physician in Chief at the R Adams Cowley Shock Trauma Center. “We have been privileged to train military personnel at my institution for many years, and that partnership has produced better care for soldiers and for our civilian patients. This funding represents a huge step forward in that military/civilian partnership, and all of us at CNTR were delighted to support this. We all look forward to seeing tangible results that help save lives over a relatively short period of time.”

The Coalition for National Trauma Research (CNTR), a 501 c3 non-profit organization, was launched in 2014 with the goal to secure federal funding for trauma-related research. “Trauma research has never been funded adequately compared to the societal burden of traumatic injury,” said Jerry Jurkovich, MD, chair of the National Trauma Institute, another CNTR member. “We’re grateful for the leadership of Maryland Congressman Dutch Ruppersberger and Texas Congressmen Joaquin Castro and Lamar Smith, who were instrumental in gaining the signatures of nearly 50 members of the U.S. House of Representatives on a letter of support for this measure to the Appropriations Committee.”

CNTR comprises the American Association for the Surgery of Trauma, National Trauma Institute, Eastern Association for the Surgery of Trauma, American College of Surgeons-Committee on Trauma and Western Trauma Association. To learn more, visit

FDA Clears Military Traumatic Wound Dressing for Civilian Use

Tuesday, December 8th, 2015

XSTAT 30 is an expandable, multi-sponge dressing that has been used on the battlefield to control severe, life-threatening bleeding that is non-compressible (in locations like the torso, groin or armpit where a tourniquet cannot be placed). The FDA’s clearance yesterday expands the device’s indication from use in military settings only to use in adults and adolescents in civilian settings.

“When a product is developed for use in the battlefield, it is generally intended to work in a worst-case scenario where advanced care might not be immediately available,” said William Maisel, M.D., M.P.H., in the FDA’s press release on the clearance. Maisel is acting director of the Office of Device Evaluation in the FDA’s Center for Devices and Radiological Health.

XSTAT 30 may now be used in patients at high risk for severe hemorrhagic shock and non-compressible wounds when definitive care at an emergency care facility cannot be achieved within minutes.

Read More.